Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Aaron W. Gehr"'
Autor:
Rachel J. Meadows, Aaron W. Gehr, Yan Lu, Grace Maynard, Idara N. Akpan, Tanjila Taskin, Kimberly G. Fulda, Divya Patel, Sarah Matches, Rohit P. Ojha, Erika L. Thompson
Publikováno v:
Preventive Medicine Reports, Vol 39, Iss , Pp 102660- (2024)
Background: Strong provider recommendation can increase uptake of human papillomavirus (HPV) vaccination. Therefore, we developed and implemented a provider education intervention on communication strategies for recommending HPV vaccination with clin
Externí odkaz:
https://doaj.org/article/f064d2d823264eff8cb5157ad3aa6125
Autor:
Yan Lu, Aaron W. Gehr, Rachel J. Meadows, Bassam Ghabach, Latha Neerukonda, Kalyani Narra, Rohit P. Ojha
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Prior studies reported survival benefits from early initiation of adjuvant chemotherapy for stage III colon cancer, but this evidence was derived from studies that may be sensitive to time-related biases. Therefore, we aimed to es
Externí odkaz:
https://doaj.org/article/1cbed1dfcbc94fdf83c4b66b766841d4
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background We aimed to estimate the effects of smoking cessation on survival among people diagnosed with cancer. Methods We used data from a Comprehensive Community Cancer Program that is part of a large urban safety-net hospital system. Eli
Externí odkaz:
https://doaj.org/article/9afc9950e0fa440bb70cdf2a22aca447
Autor:
Rachel Meadows, Yan Lu, Grace Maynard, Idara N. Akpan, Aaron W. Gehr, Tanjila Taskin, Kimberly Fulda, Divya Patel, Rohit P. Ojha, Erika L. Thompson
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-148
Autor:
Yan Lu, Aaron W. Gehr, Ifedioranma Anikpo, Rachel J. Meadows, Kevin J. Craten, Rim Bannout, Kalyani Narra, Anuradha Lingam, Bhavna Tanna, Bassam Ghabach, Rohit P. Ojha
Publikováno v:
Cancer Research. 82:P5-14
Background Current knowledge of cardiotoxicity risk after breast cancer treatment with anthracyclines or trastuzumab is largely derived from cohorts that under-represent socioeconomically disadvantaged patients. Cardiotoxicity risk among socioeconomi
Autor:
Rohit P. Ojha, Aaron W. Gehr, Anuradha Lingam, Rachel J. Meadows, Kalyani Narra, Yan Lu, Bassam Ghabach
Publikováno v:
Annals of Epidemiology. 65:31-37
We aimed to assess whether differences in the distributions of prognostic factors explain reported mortality disparities between urban safety-net and Surveillance, Epidemiology, and End Results (SEER) cancer populations.We used data from SEER and a s
Autor:
Yan Lu, Aaron W. Gehr, Ifedioranma Anikpo, Rachel J. Meadows, Kevin J. Craten, Kalyani Narra, Anuradha Lingam, Sandeep Kamath, Bhavna Tanna, Bassam Ghabach, Rohit P. Ojha
Publikováno v:
Breast cancer research and treatment. 195(3)
Purpose Evidence of cardiotoxicity risk related to anthracycline or trastuzumab exposure is largely derived from breast cancer cohorts that under-represent socioeconomically marginalized women, who may be at increased risk of cardiotoxicity because o
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background We aimed to estimate the effects of smoking cessation on survival among people diagnosed with cancer. Methods We used data from a Comprehensive Community Cancer Program that is part of a large urban safety-net hospital system. Eligible pat
Autor:
Bhavna Tanna, Aaron W. Gehr, Tara M. Brinkman, Kalyani Narra, Yan Lu, Margaret M. Lubas, Bassam Ghabach, Rohit P. Ojha
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Limited information is available about the representativeness of survivors engaging in patient-centered research, despite the potential for threats to generalizability. We thus aimed to assess the representativeness of survivors engaged o
Autor:
Yan Lu, Aaron W. Gehr, Rachel J. Meadows, Bassam Ghabach, Latha Neerukonda, Kalyani Narra, Rohit P. Ojha
Publikováno v:
BMC cancer. 22(1)
Background Prior studies reported survival benefits from early initiation of adjuvant chemotherapy for stage III colon cancer, but this evidence was derived from studies that may be sensitive to time-related biases. Therefore, we aimed to estimate th